Literature DB >> 24336502

Viral diseases: Zeroing in on RSV vaccine design.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24336502     DOI： 10.1038/nrd4207

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

Authors:  Jason S McLellan; Man Chen; M Gordon Joyce; Mallika Sastry; Guillaume B E Stewart-Jones; Yongping Yang; Baoshan Zhang; Lei Chen; Sanjay Srivatsan; Anqi Zheng; Tongqing Zhou; Kevin W Graepel; Azad Kumar; Syed Moin; Jeffrey C Boyington; Gwo-Yu Chuang; Cinque Soto; Ulrich Baxa; Arjen Q Bakker; Hergen Spits; Tim Beaumont; Zizheng Zheng; Ningshao Xia; Sung-Youl Ko; John-Paul Todd; Srinivas Rao; Barney S Graham; Peter D Kwong
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728
  1 in total
  2 in total

1.  Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection.

Authors:  Hai Li; Hu Ren; Yan Zhang; Lei Cao; Wenbo Xu
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

2.  HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.

Authors:  Hai Li; Hu Ren; Yangzi Zhou; Yan Zhang; Lei Cao; Wenbo Xu
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.